Medpace Holdings (MEDP) Current Deferred Revenue (2015 - 2026)

Medpace Holdings has reported Current Deferred Revenue for 12 years, with the latest figure at $856.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 19.15% year-over-year to $856.3 million; the trailing twelve-month figure through Mar 2026 stood at $856.3 million (up 19.15% YoY), and the FY2025 full-year result was $854.4 million, up 20.24% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $856.3 million, roughly flat from $854.4 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $856.3 million in Q1 2026, with the low at $367.2 million in Q1 2022.
• Historically, Current Deferred Revenue has averaged $611.4 million across 5 years, with a median of $616.7 million in 2024.
• Annual changes were most pronounced in 2022 — Current Deferred Revenue soared 42.22% — and 2025, when it rose 16.54%.
• Medpace Holdings' Current Deferred Revenue stood at $462.7 million in 2022, then rose by 20.99% to $559.9 million in 2023, then rose by 26.92% to $710.6 million in 2024, then gained by 20.24% to $854.4 million in 2025, then grew by 0.23% to $856.3 million in 2026.
• The last three Current Deferred Revenue figures came in at $856.3 million (Q1 2026), $854.4 million (Q4 2025), and $834.3 million (Q3 2025), per Business Quant data.